Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Provision of OMS721 to Patients With Thrombotic Microangiopathy Under Compassionate Use

NCT02355782 is registered in ClinicalTrials.gov with Michal Nowicki as lead sponsor.

NCT NCT02355782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02355782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Provision of OMS721 to Patients With Thrombotic Microangiopathy Under Compassionate Use
Lead sponsor
Michal Nowicki
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic microangiopathy